HealthEquity Stock Alpha and Beta Analysis


USD 66.99  0.51  0.77%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as HealthEquity. It also helps investors analyze the systematic and unsystematic risks associated with investing in HealthEquity over a specified time horizon. Remember, high HealthEquity's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please check HealthEquity Backtesting, HealthEquity Valuation, HealthEquity Correlation, HealthEquity Hype Analysis, HealthEquity Volatility, HealthEquity History and analyze HealthEquity Performance.
Please note that although HealthEquity alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, HealthEquity did 0.06  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of HealthEquity stock's relative risk over its benchmark. HealthEquity has a beta of 0.0301  . Let's try to break down what HealthEquity's beta means in this case. As returns on the market increase, returns on owning HealthEquity are expected to decrease at a much lower rate. During the bear market, HealthEquity is likely to outperform the market.
HealthEquity Book Value per Share is fairly stable at the moment as compared to the past year. HealthEquity reported Book Value per Share of 22.28 in 2021. Enterprise Value over EBITDA is likely to rise to 48.80 in 2022, whereas Enterprise Value over EBIT is likely to drop (164.21)  in 2022.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Enterprise Value

4.65 Billion

HealthEquity Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. HealthEquity market risk premium is the additional return an investor will receive from holding HealthEquity long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in HealthEquity. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate HealthEquity's performance over market.
α0.06   β-0.03
90 days against NYA

HealthEquity expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of HealthEquity's Buy-and-hold return. Our buy-and-hold chart shows how HealthEquity performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

HealthEquity Market Price Analysis

Market price analysis indicators help investors to evaluate how HealthEquity stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HealthEquity shares will generate the highest return on investment. By understating and applying HealthEquity stock market price indicators, traders can identify HealthEquity position entry and exit signals to maximize returns.

HealthEquity Return and Market Media

The median price of HealthEquity for the period between Thu, Sep 8, 2022 and Wed, Dec 7, 2022 is 69.05 with a coefficient of variation of 7.39. The daily time series for the period is distributed with a sample standard deviation of 5.11, arithmetic mean of 69.15, and mean deviation of 4.37. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
StartUp Health Launches Health Equity Moonshot at Clinton Gl...09/19/2022
Kate B. Reynolds Charitable Trust to divest from tobacco, fo...09/27/2022
Sale by Debra McCowan of 4225 shares of Healthequity09/29/2022
Second Annual RARE Health Equity Summit Addresses Gaps in Ac...10/05/2022
Is G1 Therapeutics Outperforming Other Medical Stocks This Y...10/12/2022
Exercise or conversion by Larry Trittschuh of 6419 shares of...10/17/2022
EPS Estimate10/31/2022
Is HealthEquity, Inc. Expensive For A Reason A Look At Its I...11/11/2022
Stock Upgrades HealthEquity Shows Rising Relative Strength I...11/18/2022
EPS Reported12/06/2022

About HealthEquity Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including HealthEquity or other stocks. Alpha measures the amount that position in HealthEquity has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2020 2021 2022 (projected)
Long Term Debt to Equity0.670.50.71
Interest Coverage1.011.161.19

HealthEquity Upcoming Company Events

As portrayed in its financial statements, the presentation of HealthEquity's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HealthEquity's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of HealthEquity's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of HealthEquity. Please utilize our Beneish M Score to check the likelihood of HealthEquity's management manipulating its earnings.
Upcoming Quarterly Report21st of March 2022
Next Financial Report6th of June 2022
Next Fiscal Quarter End31st of January 2022
Next Fiscal Year End21st of March 2022
Last Quarter Report31st of October 2021
Last Financial Announcement31st of January 2021

Build Portfolio with HealthEquity

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check HealthEquity Backtesting, HealthEquity Valuation, HealthEquity Correlation, HealthEquity Hype Analysis, HealthEquity Volatility, HealthEquity History and analyze HealthEquity Performance. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for analysis

When running HealthEquity price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
HealthEquity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of HealthEquity technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of HealthEquity trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...